<!doctype html>
<html>
<head>
<meta charset='UTF-8'><meta name='viewport' content='width=device-width initial-scale=1'><style type='text/css'>html {overflow-x: initial !important;}</style>
<style type='text/css'  id="style-base">:root { --bg-color: #ffffff; --text-color: #333333; --select-text-bg-color: #B5D6FC; --select-text-font-color: auto; --monospace: "Lucida Console",Consolas,"Courier",monospace; --title-bar-height: 20px; }
.mac-os-11 { --title-bar-height: 28px; }
html { font-size: 14px; background-color: var(--bg-color); color: var(--text-color); font-family: "Helvetica Neue", Helvetica, Arial, "Segoe UI Emoji", "SF Pro", sans-serif; -webkit-font-smoothing: antialiased; }
h1, h2, h3, h4, h5 { white-space: pre-wrap; }
body { margin: 0px; padding: 0px; height: auto; inset: 0px; font-size: 1rem; line-height: 1.42857; overflow-x: hidden; background: inherit; }
iframe { margin: auto; }
a.url { word-break: break-all; }
a:active, a:hover { outline: 0px; }
.in-text-selection, ::selection { text-shadow: none; background: var(--select-text-bg-color); color: var(--select-text-font-color); }
#write { margin: 0px auto; height: auto; width: inherit; word-break: normal; overflow-wrap: break-word; position: relative; white-space: normal; overflow-x: visible; padding-top: 36px; }
#write.first-line-indent p { text-indent: 2em; }
#write.first-line-indent li p, #write.first-line-indent p *, #write.first-line-indent svg * { text-indent: 0px; }
#write.first-line-indent li { margin-left: 2em; }
.for-image #write { padding-left: 8px; padding-right: 8px; }
body.typora-export { padding-left: 30px; padding-right: 30px; }
.typora-export .footnote-line, .typora-export li, .typora-export p { white-space: pre-wrap; }
.typora-export .task-list-item input { pointer-events: none; }
@media screen and (max-width: 500px) {
  body.typora-export { padding-left: 0px; padding-right: 0px; }
  #write { padding-left: 20px; padding-right: 20px; }
}
#write li > figure:last-child { margin-bottom: 0.5rem; }
#write ol, #write ul { position: relative; }
img { max-width: 100%; vertical-align: middle; image-orientation: from-image; }
button, input, select, textarea { color: inherit; font: inherit; }
input[type="checkbox"], input[type="radio"] { line-height: normal; padding: 0px; }
*, ::after, ::before { box-sizing: border-box; }
#write h1, #write h2, #write h3, #write h4, #write h5, #write h6, #write p, #write pre { width: inherit; position: relative; }
#write svg h1, #write svg h2, #write svg h3, #write svg h4, #write svg h5, #write svg h6, #write svg p { position: static; white-space: nowrap; overflow: visible; }
foreignobject { overflow: visible; }
p { line-height: inherit; }
h1, h2, h3, h4, h5, h6 { break-after: avoid-page; break-inside: avoid; orphans: 4; }
p { orphans: 4; }
li p { orphans: 1; }
h1 { font-size: 2rem; }
h2 { font-size: 1.8rem; }
h3 { font-size: 1.6rem; }
h4 { font-size: 1.4rem; }
h5 { font-size: 1.2rem; }
h6 { font-size: 1rem; }
.md-math-block, .md-rawblock, h1, h2, h3, h4, h5, h6, p { margin-top: 1rem; margin-bottom: 1rem; }
.hidden { display: none; }
.md-blockmeta { color: rgb(204, 204, 204); font-weight: 700; font-style: italic; }
a { cursor: pointer; }
sup.md-footnote { padding: 2px 4px; background-color: rgba(238, 238, 238, 0.7); color: rgb(85, 85, 85); border-radius: 4px; cursor: pointer; }
sup.md-footnote a, sup.md-footnote a:hover { color: inherit; text-transform: inherit; text-decoration: inherit; }
#write input[type="checkbox"] { cursor: pointer; width: inherit; height: inherit; }
figure { overflow-x: auto; margin: 1.2em 0px; max-width: calc(100% + 16px); padding: 0px; }
figure > table { margin: 0px; }
thead, tr { break-inside: avoid; break-after: auto; }
thead { display: table-header-group; }
table { border-collapse: collapse; border-spacing: 0px; width: 100%; overflow: auto; break-inside: auto; text-align: left; }
table.md-table td { min-width: 32px; }
.CodeMirror-gutters { border-right: 0px; background-color: inherit; }
.CodeMirror-linenumber { user-select: none; }
.CodeMirror { text-align: left; }
.CodeMirror-placeholder { opacity: 0.3; }
.CodeMirror pre { padding: 0px 4px; }
.CodeMirror-lines { padding: 0px; }
div.hr:focus { cursor: none; }
#write pre { white-space: pre-wrap; }
#write.fences-no-line-wrapping pre { white-space: pre; }
#write pre.ty-contain-cm { white-space: normal; }
.CodeMirror-gutters { margin-right: 4px; }
.md-fences { font-size: 0.9rem; display: block; break-inside: avoid; text-align: left; overflow: visible; white-space: pre; background: inherit; position: relative !important; }
.md-fences-adv-panel { width: 100%; margin-top: 10px; text-align: center; padding-top: 0px; padding-bottom: 8px; overflow-x: auto; }
#write .md-fences.mock-cm { white-space: pre-wrap; }
.md-fences.md-fences-with-lineno { padding-left: 0px; }
#write.fences-no-line-wrapping .md-fences.mock-cm { white-space: pre; overflow-x: auto; }
.md-fences.mock-cm.md-fences-with-lineno { padding-left: 8px; }
.CodeMirror-line, twitterwidget { break-inside: avoid; }
svg { break-inside: avoid; }
.footnotes { opacity: 0.8; font-size: 0.9rem; margin-top: 1em; margin-bottom: 1em; }
.footnotes + .footnotes { margin-top: 0px; }
.md-reset { margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: top; background: 0px 0px; text-decoration: none; text-shadow: none; float: none; position: static; width: auto; height: auto; white-space: nowrap; cursor: inherit; -webkit-tap-highlight-color: transparent; line-height: normal; font-weight: 400; text-align: left; box-sizing: content-box; direction: ltr; }
li div { padding-top: 0px; }
blockquote { margin: 1rem 0px; }
li .mathjax-block, li p { margin: 0.5rem 0px; }
li blockquote { margin: 1rem 0px; }
li { margin: 0px; position: relative; }
blockquote > :last-child { margin-bottom: 0px; }
blockquote > :first-child, li > :first-child { margin-top: 0px; }
.footnotes-area { color: rgb(136, 136, 136); margin-top: 0.714rem; padding-bottom: 0.143rem; white-space: normal; }
#write .footnote-line { white-space: pre-wrap; }
@media print {
  body, html { border: 1px solid transparent; height: 99%; break-after: avoid; break-before: avoid; font-variant-ligatures: no-common-ligatures; }
  #write { margin-top: 0px; border-color: transparent !important; padding-top: 0px !important; padding-bottom: 0px !important; }
  .typora-export * { -webkit-print-color-adjust: exact; }
  .typora-export #write { break-after: avoid; }
  .typora-export #write::after { height: 0px; }
  .is-mac table { break-inside: avoid; }
  #write > p:nth-child(1) { margin-top: 0px; }
  .typora-export-show-outline .typora-export-sidebar { display: none; }
  figure { overflow-x: visible; }
}
.footnote-line { margin-top: 0.714em; font-size: 0.7em; }
a img, img a { cursor: pointer; }
pre.md-meta-block { font-size: 0.8rem; min-height: 0.8rem; white-space: pre-wrap; background: rgb(204, 204, 204); display: block; overflow-x: hidden; }
p > .md-image:only-child:not(.md-img-error) img, p > img:only-child { display: block; margin: auto; }
#write.first-line-indent p > .md-image:only-child:not(.md-img-error) img { left: -2em; position: relative; }
p > .md-image:only-child { display: inline-block; width: 100%; }
#write .MathJax_Display { margin: 0.8em 0px 0px; }
.md-math-block { width: 100%; }
.md-math-block:not(:empty)::after { display: none; }
.MathJax_ref { fill: currentcolor; }
[contenteditable="true"]:active, [contenteditable="true"]:focus, [contenteditable="false"]:active, [contenteditable="false"]:focus { outline: 0px; box-shadow: none; }
.md-task-list-item { position: relative; list-style-type: none; }
.task-list-item.md-task-list-item { padding-left: 0px; }
.md-task-list-item > input { position: absolute; top: 0px; left: 0px; margin-left: -1.2em; margin-top: calc(1em - 10px); border: none; }
.math { font-size: 1rem; }
.md-toc { min-height: 3.58rem; position: relative; font-size: 0.9rem; border-radius: 10px; }
.md-toc-content { position: relative; margin-left: 0px; }
.md-toc-content::after, .md-toc::after { display: none; }
.md-toc-item { display: block; color: rgb(65, 131, 196); }
.md-toc-item a { text-decoration: none; }
.md-toc-inner:hover { text-decoration: underline; }
.md-toc-inner { display: inline-block; cursor: pointer; }
.md-toc-h1 .md-toc-inner { margin-left: 0px; font-weight: 700; }
.md-toc-h2 .md-toc-inner { margin-left: 2em; }
.md-toc-h3 .md-toc-inner { margin-left: 4em; }
.md-toc-h4 .md-toc-inner { margin-left: 6em; }
.md-toc-h5 .md-toc-inner { margin-left: 8em; }
.md-toc-h6 .md-toc-inner { margin-left: 10em; }
@media screen and (max-width: 48em) {
  .md-toc-h3 .md-toc-inner { margin-left: 3.5em; }
  .md-toc-h4 .md-toc-inner { margin-left: 5em; }
  .md-toc-h5 .md-toc-inner { margin-left: 6.5em; }
  .md-toc-h6 .md-toc-inner { margin-left: 8em; }
}
a.md-toc-inner { font-size: inherit; font-style: inherit; font-weight: inherit; line-height: inherit; }
.footnote-line a:not(.reversefootnote) { color: inherit; }
.reversefootnote { font-family: ui-monospace, sans-serif; }
.md-attr { display: none; }
.md-fn-count::after { content: "."; }
code, pre, samp, tt { font-family: var(--monospace); }
kbd { margin: 0px 0.1em; padding: 0.1em 0.6em; font-size: 0.8em; color: rgb(36, 39, 41); background: rgb(255, 255, 255); border: 1px solid rgb(173, 179, 185); border-radius: 3px; box-shadow: rgba(12, 13, 14, 0.2) 0px 1px 0px, rgb(255, 255, 255) 0px 0px 0px 2px inset; white-space: nowrap; vertical-align: middle; }
.md-comment { color: rgb(162, 127, 3); opacity: 0.6; font-family: var(--monospace); }
code { text-align: left; vertical-align: initial; }
a.md-print-anchor { white-space: pre !important; border-width: initial !important; border-style: none !important; border-color: initial !important; display: inline-block !important; position: absolute !important; width: 1px !important; right: 0px !important; outline: 0px !important; background: 0px 0px !important; text-decoration: initial !important; text-shadow: initial !important; }
.os-windows.monocolor-emoji .md-emoji { font-family: "Segoe UI Symbol", sans-serif; }
.md-diagram-panel > svg { max-width: 100%; }
[lang="flow"] svg, [lang="mermaid"] svg { max-width: 100%; height: auto; }
[lang="mermaid"] .node text { font-size: 1rem; }
table tr th { border-bottom: 0px; }
video { max-width: 100%; display: block; margin: 0px auto; }
iframe { max-width: 100%; width: 100%; border: none; }
.highlight td, .highlight tr { border: 0px; }
mark { background: rgb(255, 255, 0); color: rgb(0, 0, 0); }
.md-html-inline .md-plain, .md-html-inline strong, mark .md-inline-math, mark strong { color: inherit; }
.md-expand mark .md-meta { opacity: 0.3 !important; }
mark .md-meta { color: rgb(0, 0, 0); }
@media print {
  .typora-export h1, .typora-export h2, .typora-export h3, .typora-export h4, .typora-export h5, .typora-export h6 { break-inside: avoid; }
}
.md-diagram-panel .messageText { stroke: none !important; }
.md-diagram-panel .start-state { fill: var(--node-fill); }
.md-diagram-panel .edgeLabel rect { opacity: 1 !important; }
.md-fences.md-fences-math { font-size: 1em; }
.md-fences-advanced:not(.md-focus) { padding: 0px; white-space: nowrap; border: 0px; }
.md-fences-advanced:not(.md-focus) { background: inherit; }
.mermaid-svg { margin: auto; }
.typora-export-show-outline .typora-export-content { max-width: 1440px; margin: auto; display: flex; flex-direction: row; }
.typora-export-sidebar { width: 300px; font-size: 0.8rem; margin-top: 80px; margin-right: 18px; }
.typora-export-show-outline #write { --webkit-flex: 2; flex: 2 1 0%; }
.typora-export-sidebar .outline-content { position: fixed; top: 0px; max-height: 100%; overflow: hidden auto; padding-bottom: 30px; padding-top: 60px; width: 300px; }
@media screen and (max-width: 1024px) {
  .typora-export-sidebar, .typora-export-sidebar .outline-content { width: 240px; }
}
@media screen and (max-width: 800px) {
  .typora-export-sidebar { display: none; }
}
.outline-content li, .outline-content ul { margin-left: 0px; margin-right: 0px; padding-left: 0px; padding-right: 0px; list-style: none; overflow-wrap: anywhere; }
.outline-content ul { margin-top: 0px; margin-bottom: 0px; }
.outline-content strong { font-weight: 400; }
.outline-expander { width: 1rem; height: 1.42857rem; position: relative; display: table-cell; vertical-align: middle; cursor: pointer; padding-left: 4px; }
.outline-expander::before { content: ""; position: relative; font-family: Ionicons; display: inline-block; font-size: 8px; vertical-align: middle; }
.outline-item { padding-top: 3px; padding-bottom: 3px; cursor: pointer; }
.outline-expander:hover::before { content: ""; }
.outline-h1 > .outline-item { padding-left: 0px; }
.outline-h2 > .outline-item { padding-left: 1em; }
.outline-h3 > .outline-item { padding-left: 2em; }
.outline-h4 > .outline-item { padding-left: 3em; }
.outline-h5 > .outline-item { padding-left: 4em; }
.outline-h6 > .outline-item { padding-left: 5em; }
.outline-label { cursor: pointer; display: table-cell; vertical-align: middle; text-decoration: none; color: inherit; }
.outline-label:hover { text-decoration: underline; }
.outline-item:hover { border-color: rgb(245, 245, 245); background-color: var(--item-hover-bg-color); }
.outline-item:hover { margin-left: -28px; margin-right: -28px; border-left: 28px solid transparent; border-right: 28px solid transparent; }
.outline-item-single .outline-expander::before, .outline-item-single .outline-expander:hover::before { display: none; }
.outline-item-open > .outline-item > .outline-expander::before { content: ""; }
.outline-children { display: none; }
.info-panel-tab-wrapper { display: none; }
.outline-item-open > .outline-children { display: block; }
.typora-export .outline-item { padding-top: 1px; padding-bottom: 1px; }
.typora-export .outline-item:hover { margin-right: -8px; border-right: 8px solid transparent; }
.typora-export .outline-expander::before { content: "+"; font-family: inherit; top: -1px; }
.typora-export .outline-expander:hover::before, .typora-export .outline-item-open > .outline-item > .outline-expander::before { content: "−"; }
.typora-export-collapse-outline .outline-children { display: none; }
.typora-export-collapse-outline .outline-item-open > .outline-children, .typora-export-no-collapse-outline .outline-children { display: block; }
.typora-export-no-collapse-outline .outline-expander::before { content: "" !important; }
.typora-export-show-outline .outline-item-active > .outline-item .outline-label { font-weight: 700; }
.md-inline-math-container mjx-container { zoom: 0.95; }
mjx-container { break-inside: avoid; }
.md-alert.md-alert-note { border-left-color: rgb(9, 105, 218); }
.md-alert.md-alert-important { border-left-color: rgb(130, 80, 223); }
.md-alert.md-alert-warning { border-left-color: rgb(154, 103, 0); }
.md-alert.md-alert-tip { border-left-color: rgb(31, 136, 61); }
.md-alert.md-alert-caution { border-left-color: rgb(207, 34, 46); }
.md-alert { padding: 0px 1em; margin-bottom: 16px; color: inherit; border-left: 0.25em solid rgb(0, 0, 0); }
.md-alert-text-note { color: rgb(9, 105, 218); }
.md-alert-text-important { color: rgb(130, 80, 223); }
.md-alert-text-warning { color: rgb(154, 103, 0); }
.md-alert-text-tip { color: rgb(31, 136, 61); }
.md-alert-text-caution { color: rgb(207, 34, 46); }
.md-alert-text { font-size: 0.9rem; font-weight: 700; }
.md-alert-text svg { fill: currentcolor; position: relative; top: 0.125em; margin-right: 1ch; overflow: visible; }
.md-alert-text-container::after { content: attr(data-text); text-transform: capitalize; pointer-events: none; margin-right: 1ch; }

</style>
<link rel='stylesheet' href='https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,700,400&amp;subset=latin,latin-ext' type='text/css' />
<style type='text/css'  id="style-theme_css">:root {
    --side-bar-bg-color: #fafafa;
    --control-text-color: #777;
}

@include-when-export url(https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,700,400&subset=latin,latin-ext);

/* open-sans-regular - latin-ext_latin */
  /* open-sans-italic - latin-ext_latin */
    /* open-sans-700 - latin-ext_latin */
    /* open-sans-700italic - latin-ext_latin */
  html {
    font-size: 16px;
    -webkit-font-smoothing: antialiased;
}

body {
    font-family: "Open Sans","Clear Sans", "Helvetica Neue", Helvetica, Arial, 'Segoe UI Emoji', 'SF Pro', sans-serif;
    color: rgb(51, 51, 51);
    line-height: 1.6;
}

#write {
    max-width: 860px;
  	margin: 0 auto;
  	padding: 30px;
    padding-bottom: 100px;
}

@media only screen and (min-width: 1400px) {
	#write {
		max-width: 1024px;
	}
}

@media only screen and (min-width: 1800px) {
	#write {
		max-width: 1200px;
	}
}

#write > ul:first-child,
#write > ol:first-child{
    margin-top: 30px;
}

a {
    color: #4183C4;
}
h1,
h2,
h3,
h4,
h5,
h6 {
    position: relative;
    margin-top: 1rem;
    margin-bottom: 1rem;
    font-weight: bold;
    line-height: 1.4;
    cursor: text;
}
h1:hover a.anchor,
h2:hover a.anchor,
h3:hover a.anchor,
h4:hover a.anchor,
h5:hover a.anchor,
h6:hover a.anchor {
    text-decoration: none;
}
h1 tt,
h1 code {
    font-size: inherit;
}
h2 tt,
h2 code {
    font-size: inherit;
}
h3 tt,
h3 code {
    font-size: inherit;
}
h4 tt,
h4 code {
    font-size: inherit;
}
h5 tt,
h5 code {
    font-size: inherit;
}
h6 tt,
h6 code {
    font-size: inherit;
}
h1 {
    font-size: 2.25em;
    line-height: 1.2;
    border-bottom: 1px solid #eee;
}
h2 {
    font-size: 1.75em;
    line-height: 1.225;
    border-bottom: 1px solid #eee;
}

/*@media print {
    .typora-export h1,
    .typora-export h2 {
        border-bottom: none;
        padding-bottom: initial;
    }

    .typora-export h1::after,
    .typora-export h2::after {
        content: "";
        display: block;
        height: 100px;
        margin-top: -96px;
        border-top: 1px solid #eee;
    }
}*/

h3 {
    font-size: 1.5em;
    line-height: 1.43;
}
h4 {
    font-size: 1.25em;
}
h5 {
    font-size: 1em;
}
h6 {
   font-size: 1em;
    color: #777;
}
p,
blockquote,
ul,
ol,
dl,
table{
    margin: 0.8em 0;
}
li>ol,
li>ul {
    margin: 0 0;
}
hr {
    height: 2px;
    padding: 0;
    margin: 16px 0;
    background-color: #e7e7e7;
    border: 0 none;
    overflow: hidden;
    box-sizing: content-box;
}

li p.first {
    display: inline-block;
}
ul,
ol {
    padding-left: 30px;
}
ul:first-child,
ol:first-child {
    margin-top: 0;
}
ul:last-child,
ol:last-child {
    margin-bottom: 0;
}
blockquote {
    border-left: 4px solid #dfe2e5;
    padding: 0 15px;
    color: #777777;
}
blockquote blockquote {
    padding-right: 0;
}
table {
    padding: 0;
    word-break: initial;
}
table tr {
    border: 1px solid #dfe2e5;
    margin: 0;
    padding: 0;
}
table tr:nth-child(2n),
thead {
    background-color: #f8f8f8;
}
table th {
    font-weight: bold;
    border: 1px solid #dfe2e5;
    border-bottom: 0;
    margin: 0;
    padding: 6px 13px;
}
table td {
    border: 1px solid #dfe2e5;
    margin: 0;
    padding: 6px 13px;
}
table th:first-child,
table td:first-child {
    margin-top: 0;
}
table th:last-child,
table td:last-child {
    margin-bottom: 0;
}

.CodeMirror-lines {
    padding-left: 4px;
}

.code-tooltip {
    box-shadow: 0 1px 1px 0 rgba(0,28,36,.3);
    border-top: 1px solid #eef2f2;
}

.md-fences,
code,
tt {
    border: 1px solid #e7eaed;
    background-color: #f8f8f8;
    border-radius: 3px;
    padding: 0;
    padding: 2px 4px 0px 4px;
    font-size: 0.9em;
}

code {
    background-color: #f3f4f4;
    padding: 0 2px 0 2px;
}

.md-fences {
    margin-bottom: 15px;
    margin-top: 15px;
    padding-top: 8px;
    padding-bottom: 6px;
}


.md-task-list-item > input {
  margin-left: -1.3em;
}

@media print {
    html {
        font-size: 13px;
    }
    pre {
        page-break-inside: avoid;
        word-wrap: break-word;
    }
}

.md-fences {
	background-color: #f8f8f8;
}
#write pre.md-meta-block {
	padding: 1rem;
    font-size: 85%;
    line-height: 1.45;
    background-color: #f7f7f7;
    border: 0;
    border-radius: 3px;
    color: #777777;
    margin-top: 0 !important;
}

.mathjax-block>.code-tooltip {
	bottom: .375rem;
}

.md-mathjax-midline {
    background: #fafafa;
}

#write>h3.md-focus:before{
	left: -1.5625rem;
	top: .375rem;
}
#write>h4.md-focus:before{
	left: -1.5625rem;
	top: .285714286rem;
}
#write>h5.md-focus:before{
	left: -1.5625rem;
	top: .285714286rem;
}
#write>h6.md-focus:before{
	left: -1.5625rem;
	top: .285714286rem;
}
.md-image>.md-meta {
    /*border: 1px solid #ddd;*/
    border-radius: 3px;
    padding: 2px 0px 0px 4px;
    font-size: 0.9em;
    color: inherit;
}

.md-tag {
    color: #a7a7a7;
    opacity: 1;
}

.md-toc { 
    margin-top:20px;
    padding-bottom:20px;
}

.sidebar-tabs {
    border-bottom: none;
}

#typora-quick-open {
    border: 1px solid #ddd;
    background-color: #f8f8f8;
}

#typora-quick-open-item {
    background-color: #FAFAFA;
    border-color: #FEFEFE #e5e5e5 #e5e5e5 #eee;
    border-style: solid;
    border-width: 1px;
}

/** focus mode */
.on-focus-mode blockquote {
    border-left-color: rgba(85, 85, 85, 0.12);
}

header, .context-menu, .megamenu-content, footer{
    font-family: "Segoe UI", "Arial", sans-serif;
}

.file-node-content:hover .file-node-icon,
.file-node-content:hover .file-node-open-state{
    visibility: visible;
}

.mac-seamless-mode #typora-sidebar {
    background-color: #fafafa;
    background-color: var(--side-bar-bg-color);
}

.mac-os #write{
    caret-color: AccentColor;
}

.md-lang {
    color: #b4654d;
}

/*.html-for-mac {
    --item-hover-bg-color: #E6F0FE;
}*/

#md-notification .btn {
    border: 0;
}

.dropdown-menu .divider {
    border-color: #e5e5e5;
    opacity: 0.4;
}

.ty-preferences .window-content {
    background-color: #fafafa;
}

.ty-preferences .nav-group-item.active {
    color: white;
    background: #999;
}

.menu-item-container a.menu-style-btn {
    background-color: #f5f8fa;
    background-image: linear-gradient( 180deg , hsla(0, 0%, 100%, 0.8), hsla(0, 0%, 100%, 0)); 
}
</style>
<style type='text/css'  id="style-lp">ol, ul {padding-left: 40px}</style>

<title>ESMO25_AI_track</title>
</head>
<body class='typora-export'><div class='typora-export-content'>
<div id='write'  class=''><h1 id='ai-and-digital-health-track-at-esmo-2025'><span>AI and digital health track at ESMO 2025</span></h1><p><span>K. Porkka 22-OCT-2025</span></p><p><span>Short notes, copies of selected slides, video captures of presentations. Feel free to add comments, links etc.</span></p><p><span>See also AI-driven biomarker </span><a href='https://dailyreporter.esmo.org/esmo-congress-2025/ai-digital-oncology/new-artificial-intelligence-based-biomarkers-offer-early-insight-into-treatment-response?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=ESMO-WW-COM-Members-Delegates-ESMO25-email-newsletter-20251021-64785'><span>presentations</span></a><span>.</span></p><div class='md-toc' mdtype='toc'><p class="md-toc-content" role="list"><span role="listitem" class="md-toc-item md-toc-h1" data-ref="n689"><a class="md-toc-inner" href="#ai-and-digital-health-track-at-esmo-2025">AI and digital health track at ESMO 2025</a></span><span role="listitem" class="md-toc-item md-toc-h2" data-ref="n695"><a class="md-toc-inner" href="#session-ai-in-clinical-trials"><u>Session: AI in clinical trials</u></a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n697"><a class="md-toc-inner" href="#ai-based-procedures-to-augment-clinical-trials-a-prelaj">AI-based procedures to augment clinical trials (A. Prelaj)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n704"><a class="md-toc-inner" href="#ai-for-genomic-precision-medicine-in-clinical-trials-m-aldea">AI for genomic precision medicine in clinical trials (M. Aldea)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n707"><a class="md-toc-inner" href="#digital-infrastructure-for-clinical-trials-i-vaz-luis">Digital infrastructure for clinical trials (I. Vaz-Luis)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n711"><a class="md-toc-inner" href="#ai-based-drug-discovery-for-oncology-c-curtis">AI-based drug discovery for oncology (C. Curtis)</a></span><span role="listitem" class="md-toc-item md-toc-h2" data-ref="n717"><a class="md-toc-inner" href="#session-advancing-cancer-care-through-ai-and-real-world-evidence-opportunities-and-challenges-for-patient-advocacy"><u>Session: Advancing cancer care through AI and real-world evidence: Opportunities and challenges for patient advocacy</u></a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n719"><a class="md-toc-inner" href="#transforming-rwe-with-ai-the-future-of-data-driven-cancer-care-l-verlingue">Transforming RWE with AI: The future of data-driven cancer care (L. Verlingue)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n723"><a class="md-toc-inner" href="#ai-and-rwe-addressing-healthcare-disparities-and-improving-access-a-prelaj">AI and RWE: Addressing healthcare disparities and improving access (A. Prelaj)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n727"><a class="md-toc-inner" href="#ai-and-real-world-evidence-the-patient-advocate-experience-g-van-oortmerssen">AI and real-world evidence: The patient advocate experience (G. van Oortmerssen)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n731"><a class="md-toc-inner" href="#how-ai-can-help-detect-health-risks-early-in-breast-cancer-survivors-real-world-benefits-from-the-artillery-project-n-harbeck">How AI can help detect health risks early in breast cancer survivors: Real-world benefits from the ARTILLERY project (N. Harbeck)</a></span><span role="listitem" class="md-toc-item md-toc-h2" data-ref="n735"><a class="md-toc-inner" href="#session-chat-gpt-and-cancer-care"><u>Session: Chat GPT and cancer care</u></a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n736"><a class="md-toc-inner" href="#large-language-models-and-ai-agents-in-oncology---a-primer-j-kather">Large language models and AI agents in oncology - a primer (J. Kather)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n740"><a class="md-toc-inner" href="#lessons-learned-from-implementing-llms-in-a-cancer-centre-m-aldea">Lessons learned from implementing LLMs in a cancer centre (M. Aldea)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n744"><a class="md-toc-inner" href="#large-language-models-for-drug-development-and-cancer-therapy-l-verlingue">Large language models for drug development and cancer therapy (L. Verlingue)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n748"><a class="md-toc-inner" href="#agentic-ai-in-oncology-d-truhn">Agentic AI in oncology (D. Truhn)</a></span><span role="listitem" class="md-toc-item md-toc-h2" data-ref="n752"><a class="md-toc-inner" href="#proffered-paper-session-ai--digital-oncology"><u>Proffered paper session: AI &amp; digital oncology</u></a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n754"><a class="md-toc-inner" href="#pan-cancer-biomarkers-for-immunotherapy-response-a-pooled-analysis-of-neoadjuvant-trials-p-tan">Pan cancer biomarkers for immunotherapy response: A pooled analysis of neoadjuvant trials (P. Tan)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n757"><a class="md-toc-inner" href="#prognostic-value-of-the-combined-analysis-of-pathologists-and-artificial-intelligence-capai-in-high-risk-stage-ii-iii-colon-cancer-treated-without-chemotherapy-interim-report-from-a-nationwide-validation-m-c-bakker">Prognostic value of the combined analysis of pathologists and artificial intelligence (CAPAI) in high-risk stage II-III colon cancer treated without chemotherapy: Interim report from a nationwide validation (M-C. Bakker)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n761"><a class="md-toc-inner" href="#external-validation-of-ai-for-early-stage-lung-cancer-recurrence-prognosis-using-ct-radiomics-a-valter">External validation of AI for early-stage lung cancer recurrence prognosis using CT radiomics (A. Valter)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n765"><a class="md-toc-inner" href="#invited-discussant-a-prelaj">Invited Discussant (A. Prelaj)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n769"><a class="md-toc-inner" href="#ai-generated-synthetic-cohorts-for-accelerated-clinical-trial-design-and-collaboration-data-from-19000-patients-pts-with-metastatic-breast-cancer-mbce-saad">AI-generated synthetic cohorts for accelerated clinical trial design and collaboration: Data from 19,000 patients (Pts) with metastatic breast cancer (MBC)(E. Saad)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n773"><a class="md-toc-inner" href="#impress-norway-a-nationwide-precision-oncology-study-for-off-label-targeted-therapies---results-from-the-first-1740-patients-s-brabrand">IMPRESS-Norway: A nationwide precision-oncology study for off-label targeted therapies - Results from the first 1,740 patients (S. Brabrand)</a></span><span role="listitem" class="md-toc-item md-toc-h3" data-ref="n777"><a class="md-toc-inner" href="#invited-discussant-j-vibert">Invited Discussant (J. Vibert)</a></span></p></div><h2 id='session-ai-in-clinical-trials'><u><span>Session: AI in clinical trials</span></u></h2><p><span>Saturday, 18 October 2025</span></p><h3 id='ai-based-procedures-to-augment-clinical-trials-a-prelaj'><span>AI-based procedures to augment clinical trials (A. Prelaj)</span></h3><p><span>Arsela Prelaj (Milan, Italy)</span></p><p><span>Tools discussed: TrialMAtchAI, PyTrials, MedMatch, Trial Pathfinder (Nature), TrialTranslator (Nat Med - Flatiron)</span></p><p><span>Synthetic control arm RCTs. Pragmatic clin trials - AI helps to design</span></p><p><strong><span>Silent clinical trials</span></strong><span> - key future AI-implementation tool, see eg. </span><a href='https://www.nature.com/articles/s41746-025-01674-3' target='_blank' class='url'>https://www.nature.com/articles/s41746-025-01674-3</a></p><p><a href='https://drive.google.com/file/d/13be2C6e2FC5VLtLaZ4zAuMkaOsueXx2u/view?usp=sharing'><span>Link to presentation video</span></a><span> </span></p><p>&nbsp;</p><h3 id='ai-for-genomic-precision-medicine-in-clinical-trials-m-aldea'><span>AI for genomic precision medicine in clinical trials (M. Aldea)</span></h3><p><span>Mihaela Aldea (Villejuif, France)</span></p><p><a href='https://drive.google.com/file/d/1TcSmoW_aZt0CGxr6inpCRQCKTz4gwNPr/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='digital-infrastructure-for-clinical-trials-i-vaz-luis'><span>Digital infrastructure for clinical trials (I. Vaz-Luis)</span></h3><p><span>Ines Vaz-Luis (Villejuif, France)</span></p><p><a href='https://drive.google.com/file/d/135V8YkFwUD_OnDga9Lrj9BEZEt3wcaEc/view?usp=drive_link'><span>Link to presentation video</span></a><span> </span></p><p>&nbsp;</p><h3 id='ai-based-drug-discovery-for-oncology-c-curtis'><span>AI-based drug discovery for oncology (C. Curtis)</span></h3><p><span>Christina Curtis (Stanford, United States of America)</span></p><p><span>A fantastic, visionary presentation</span></p><p><a href='https://drive.google.com/file/d/17kcNd6TsH4WnvAS8oVr24yRStU-Iot0m/view?usp=drive_link'><span>Link to presentation video</span></a></p><p><span>Papers referenced:</span></p><p><a href='files/Hallmarks_of_AI.pdf'><span>Hallmarks_of_AI.pdf</span></a><span> </span></p><p><span>See also her ESMO2025 translational research </span><a href='https://drive.google.com/file/d/1n8S8TZZqcBdOmGdsmifm1xQKrj4biTOp/view?usp=drive_link'><span>award presentation</span></a></p><p>&nbsp;</p><p><span>Key slides:</span></p><p><img src="files/Curtis_keyslide1.png" alt="Curtis_keyslide1"></p><p>&nbsp;</p><p>&nbsp;</p><h2 id='session-advancing-cancer-care-through-ai-and-real-world-evidence-opportunities-and-challenges-for-patient-advocacy'><u><span>Session: Advancing cancer care through AI and real-world evidence: Opportunities and challenges for patient advocacy</span></u></h2><p><span>Saturday, 18 October 2025</span></p><h3 id='transforming-rwe-with-ai-the-future-of-data-driven-cancer-care-l-verlingue'><span>Transforming RWE with AI: The future of data-driven cancer care (L. Verlingue)</span></h3><p><span>Loic Verlingue (Lyon, France)</span></p><p><a href='https://drive.google.com/file/d/1ZUDeFByrVQhJTZXkgSUSJkhp8omjoPAY/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='ai-and-rwe-addressing-healthcare-disparities-and-improving-access-a-prelaj'><span>AI and RWE: Addressing healthcare disparities and improving access (A. Prelaj)</span></h3><p><span>Arsela Prelaj (Milan, Italy)</span></p><p><a href='https://drive.google.com/file/d/1jic05FqInrBGWu_HxFrz-uFwTWA1qNUq/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='ai-and-real-world-evidence-the-patient-advocate-experience-g-van-oortmerssen'><span>AI and real-world evidence: The patient advocate experience (G. van Oortmerssen)</span></h3><p><span>Gerard van Oortmerssen (Naarden, Netherlands)</span></p><p><a href='https://drive.google.com/file/d/1Ep4AQwEvFqqP3AMJxbRgRJgWMTEUQS0T/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='how-ai-can-help-detect-health-risks-early-in-breast-cancer-survivors-real-world-benefits-from-the-artillery-project-n-harbeck'><span>How AI can help detect health risks early in breast cancer survivors: Real-world benefits from the ARTILLERY project (N. Harbeck)</span></h3><p><span>Nadia Harbeck (Munich, Germany)</span></p><p><a href='https://drive.google.com/file/d/1suSs30kiiDuR_hXrlMBPQKjzOTJTDGM0/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><p>&nbsp;</p><h2 id='session-chat-gpt-and-cancer-care'><u><span>Session: Chat GPT and cancer care</span></u></h2><h3 id='large-language-models-and-ai-agents-in-oncology---a-primer-j-kather'><span>Large language models and AI agents in oncology - a primer (J. Kather)</span></h3><p><em><span>Jakob Nikolas Kather (Dresden, Germany)</span></em></p><p><span>Major issue: AI-results not validated, how should that be done at scale?</span></p><p><span>Nice overview, update to his EHA2025 presentation</span></p><p><span>Paper referenced:   </span><a href='files/Ferber_Nature_Cancer_2025.pdf'><span>Ferber_Nature_Cancer_2025.pdf</span></a><span> </span></p><p><a href='https://drive.google.com/file/d/16FxEsZvEhnYH2N-cqzjNUXdJNCQ_xs-C/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='lessons-learned-from-implementing-llms-in-a-cancer-centre-m-aldea'><span>Lessons learned from implementing LLMs in a cancer centre (M. Aldea)</span></h3><p><em><span>Mihaela Aldea (France)</span></em></p><p><span>10 000 lung cancer patients as a pilot, nation-wide data collection (small and large centers). Central harmonization, stored in a RedCap db, in their own data model</span></p><p><span>Opt-out process, 0,3% opted out! Number went down by refining the patient information to a more patient-friendly (using chapGPT!)</span></p><p><span>Prospective LLM trial on cancer ongoing in France</span></p><p><a href='https://drive.google.com/file/d/16xfsynD3rKgdSqL4T5i3lZ0wNJQ3683Z/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='large-language-models-for-drug-development-and-cancer-therapy-l-verlingue'><span>Large language models for drug development and cancer therapy (L. Verlingue)</span></h3><p><span>Loic Verlingue (Lyon, France)</span></p><p><span>Preprint of a single-cell foundation model  just published: </span><a href='https://www.biorxiv.org/content/10.1101/2025.04.14.648850v2' target='_blank' class='url'>https://www.biorxiv.org/content/10.1101/2025.04.14.648850v2</a><span> </span></p><p><a href='https://drive.google.com/file/d/13ncQ7ABzTWlMe21NEtWm3r29fEhuBJmO/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='agentic-ai-in-oncology-d-truhn'><span>Agentic AI in oncology (D. Truhn)</span></h3><p><span>Daniel Truhn (Aachen, Germany)</span></p><p><a href='https://drive.google.com/file/d/1_UNZMv6x31ud-yZ5FwUEo-5jkF42AGdR/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><p>&nbsp;</p><h2 id='proffered-paper-session-ai--digital-oncology'><u><span>Proffered paper session: AI &amp; digital oncology</span></u></h2><p><span>Monday, 20 October 2025</span></p><h3 id='pan-cancer-biomarkers-for-immunotherapy-response-a-pooled-analysis-of-neoadjuvant-trials-p-tan'><span>Pan cancer biomarkers for immunotherapy response: A pooled analysis of neoadjuvant trials (P. Tan)</span></h3><p><span>Pedro Tan (Amsterdam, Netherlands)</span></p><p><span>Paper referenced:  </span><a href='files/Tan_Nature_2025.pdf'><span>Tan_Nature_2025.pdf</span></a><span> </span></p><p><a href='https://drive.google.com/file/d/1HpfgDMcPK9UMGQzvXcE0cQeZqnbCKmJr/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='prognostic-value-of-the-combined-analysis-of-pathologists-and-artificial-intelligence-capai-in-high-risk-stage-ii-iii-colon-cancer-treated-without-chemotherapy-interim-report-from-a-nationwide-validation-m-c-bakker'><span>Prognostic value of the combined analysis of pathologists and artificial intelligence (CAPAI) in high-risk stage II-III colon cancer treated without chemotherapy: Interim report from a nationwide validation (M-C. Bakker)</span></h3><p><span>Marie-Christine Bakker (Utrecht, Netherlands)</span></p><p><a href='https://drive.google.com/file/d/1DTvY7nv9W8RotCx6JLuM-WwCRtzVNzK3/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='external-validation-of-ai-for-early-stage-lung-cancer-recurrence-prognosis-using-ct-radiomics-a-valter'><span>External validation of AI for early-stage lung cancer recurrence prognosis using CT radiomics (A. Valter)</span></h3><p><span>Ann Valter (Tallinn, Estonia)</span></p><p><a href='https://drive.google.com/file/d/1xXCLONIKeiGaqn8qCnhrIsQmioKJZ2Sp/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='invited-discussant-a-prelaj'><span>Invited Discussant (A. Prelaj)</span></h3><p><span>Arsela Prelaj (Milan, Italy)</span></p><p><a href='https://drive.google.com/file/d/19IaoSOuVzynocomfjPZhLFSug1PRWE_j/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='ai-generated-synthetic-cohorts-for-accelerated-clinical-trial-design-and-collaboration-data-from-19000-patients-pts-with-metastatic-breast-cancer-mbce-saad'><span>AI-generated synthetic cohorts for accelerated clinical trial design and collaboration: Data from 19,000 patients (Pts) with metastatic breast cancer (MBC)(E. Saad)</span></h3><p><span>Eddy Saad (Boston, United States of America)</span></p><p><a href='https://drive.google.com/file/d/1yqTIm9ZkgZRGEpWX6zrnDaxwd7LGHkv-/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='impress-norway-a-nationwide-precision-oncology-study-for-off-label-targeted-therapies---results-from-the-first-1740-patients-s-brabrand'><span>IMPRESS-Norway: A nationwide precision-oncology study for off-label targeted therapies - Results from the first 1,740 patients (S. Brabrand)</span></h3><p><span>Sigmund Brabrand (Oslo, Norway)</span></p><p><a href='https://drive.google.com/file/d/1UOSCrM93kDlTVAs65nEoDXgQTaeGY3Mh/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p><h3 id='invited-discussant-j-vibert'><span>Invited Discussant (J. Vibert)</span></h3><p><span>Julien Vibert (Villejuif, France)</span></p><p><a href='https://drive.google.com/file/d/11EyVAcYBQZvdCKHluil2VsGmS-s5F8aQ/view?usp=drive_link'><span>Link to presentation video</span></a></p><p>&nbsp;</p></div></div>
</body>
</html>